Reply to letter to editor "Cancer patients should be considered as a high-risk priority target in the COVID-19 vaccination process"
J Surg Oncol
.
2021 Sep;124(3):455.
doi: 10.1002/jso.26507.
Epub 2021 Apr 20.
Authors
Shiv Rajan
1
,
Naseem Akhtar
1
,
Vijay Kumar
1
,
Sameer Gupta
1
,
Arun Chaturvedi
1
,
Sonali Sharma
2
Affiliations
1
Department of Surgical Oncology, King George's Medical University, Lucknow, Uttar Pradesh, India.
2
Department of Gynecology and Obstetrics, King George's Medical University, Lucknow, Uttar Pradesh, India.
PMID:
33878211
PMCID:
PMC8250936
DOI:
10.1002/jso.26507
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Neoplasms*
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines